GlassScriptPhysician profile
Debra S Ibrahim
NPI 1083840763
$17,488.67
in general payments reported to CMS, 2019-2025
20 companies · $5,480 in 2025
The $5,480 reported for 2025 was more than what 97% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $172 · 2021: $5,065 · 2022: $4,318 · 2023: $1,656 · 2024: $447 · 2025: $5,480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,835 · Food and Beverage: $1,748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,835.47 |
| Food and Beverage | $1,747.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $9,243.32 | 2020-2022 | |
| Abbvie INC. | $6,926.07 | 2023-2025 | |
| Abbott Laboratories | $222.38 | 2019-2020 | |
| Stryker Corporation | $214.33 | 2019-2023 | Everest Spinal System, Cascadia Interbody System, Augment Injectable |
| Zynex Medical, INC. | $173.05 | 2025 | Nexwave |
| Nevro Corp. | $144.80 | 2019 | |
| Medtronic, INC. | $123.84 | 2024 | Intellis Adaptivestim |
| Bioventus LLC | $97.24 | 2019-2025 | Durolane |
| Davol INC. | $64.64 | 2022 | |
| Depuy Synthes Sales INC. | $39.16 | 2019-2025 | Milagro, Dynatape, Truespan Orthocord |
| Si-Bone, INC. | $38.46 | 2024 | |
| Galderma Laboratories, L.P. | $29.70 | 2022-2024 | |
| Merz North America, INC. | $26.97 | 2022 | |
| Fidia Pharma USA INC. | $26.89 | 2023 | Triluron |
| Seapearl East, INC | $22.28 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Elements, INC. | $20.40 | 2024 | |
| Integra Lifesciences Corporation | $19.61 | 2020 | |
| Boston Scientific Corporation | $19.32 | 2019 | |
| Treace Medical Concepts, INC. | $19.25 | 2025 | |
| Paratek Pharmaceuticals, INC. | $16.96 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.